FDA Inspection 1278907 — Fareva Morton Grove, Inc.

Fareva Morton Grove, Inc. — FEI 1410794

The FDA completed an inspection of Fareva Morton Grove, Inc. on August 12, 2025 in Morton Grove, IL. The inspection was classified OAI (Official Action Indicated — objectionable conditions were found and regulatory action is recommended). 7 citations were issued during this inspection. Product area: Drugs.

Inspection Details

Classification
Official Action Indicated (OAI) (OAI)
End Date
August 12, 2025
Fiscal Year
2025
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Morton Grove, IL (United States)

Citations

IDCFRDescription
117721 CFR 211.63Equipment Design, Size and Location
122721 CFR 211.67(c)Cleaning/maintenance records not kept
145021 CFR 211.113(a)Procedures for non-sterile drug products
188521 CFR 211.165(b)Microbiological testing
192021 CFR 211.166(a)(3)Valid stability test methods
197521 CFR 211.182Written records kept in individual logs
440921 CFR 211.194(a)(4)Data secured in course of each test